ABOUT US
Nativus Group unites companies working in the field of novel medicinal and therapeutic compound research, development, production and marketing.
We are NATIVUS
We are a group of companies dedicated to the advancement of pharmaceutical, wellness and cosmetics industries.
OUR WORK
Our work is focused on natural compounds found in plants that are finally regaining the well-deserved attention.
WE UNDERSTAND THE POTENTIAL
These compounds are only now coming into the spotlight and an overwhelming amount of scientific research indicates their vast potential to treat a number of the most pressing physical and mental ailments, including, among others, depression, anxiety, sleeplessness, pain and inflammation.
Group
Neurostrain is a biotechnology company developing naturally occurring active compounds intended for treatment of neurological ailments.
Nativus Trade markets and sells products developed and produced by Sanobiotec and Neurostrain. It is also developing an online sales and…
Sanobiotec is the research and development company of Nativus Group that identifies, develops and produces cannabinoids and flavonoids.
News & Media
Biotechnology | Go Vilnius
If you check out the biotechnology sector overview on Go Vilnius website, you might notice a familiar name – #Sanobiotec among fellow biotech companies operating from Vilnius. ... read more →
2020-05-25
Sanobiotec taps into potential of minor cannabinoids
Sanobiotec aims to improve the technological processes for production of these compounds and leverage their therapeutic benefits for pharmaceuticals, wellness industry and treatment of progressive illnesses, such as cancer or Alzheimer’s.... read more →
2020-05-22
Deepening the search for cannabis plant’s best kept secrets
The cannabinoids THC and CBD are the most prominent compounds in the cannabis industry and are well-known for their health benefits.... read more →
2020-05-17
When collaboration is more vital than ever, you can still rely on BIO to bring the industry together.
For 2020, the BIO International Convention will transition to a new, virtual event format, BIO Digital. This virtual gathering of the global biotech industry provides access... read more →
2020-05-11
German Government Funds Psilocybin Study for Depression
To my great pleasure, I received the notification last Monday that the reviewers in a lengthy, two-stage assessment process recommended our study “Efficacy and Safety of Psilocybin in Treatment-Resistant... read more →
2020-04-10
2020 State of the Art of Psychedelic Technology – Where Is It Heading?
It was a transformational year for psychedelics in 2019. A myriad of events changed the conversation about psychedelics worldwide. These events included scientific studies, clinical trials, and the opening of new research centers.... read more →
2020-03-14